Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELSD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,721
Award facts
- Contract value 100% obligated
- $12,720.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,720.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, carries no set-aside designation and was awarded without competing proposals, as is typical for delivery orders issued under an existing indefinite delivery contract. DMS Pharmaceutical Group specializes in distributing comprehensive pharmaceutical products and medical consumables to federal agencies, particularly the Department of Defense, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents the Department of Defense's broader $30.3 billion acquisition strategy to establish regional prime vendor contractors capable of supplying diverse pharmaceutical requirements to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FELSD?
SPE2DU26FELSD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DU26FELSD worth?
The government has obligated $12,721 on SPE2DU26FELSD.
Is contract SPE2DU26FELSD an order under another contract?
Yes. SPE2DU26FELSD is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELSD competed?
The extent of competition for SPE2DU26FELSD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award